Omda : Q1 2024 Presentation

Q1 2024 Presentation

14 May 2024

Today's presenters

Sverre Flatby		Einar Bonnevie
Chief Executive Officer		Chief Financial Officer
18 years with Omda		15 years with Omda
9.7% equity stake in Omda1)		9.7% equity stake in Omda1)

Note: 1) Through Equilibrium AS

2

Vision:

Smarter ways to a safe and healthy world

Mission:

Providing proven, focused software for health and emergency professionals to know more and work smarter.

3

Software niches - business areas

Emergency		Woman & Child		Medication Management
Managing every aspect of the		Safeguarding pregnancy,		Decision support, safe and
emergency response value chain		childbirth and infancy		effective oncology treatments

Connected Imaging

LIMS

Health Analytics

Leading imaging solutions and	End-to-end blood, cell, and tissue
secure information sharing	management

Improving the quality of medical data from collection to analysis

4

Long-term recurring revenue with minimal churn….

1

Recurring Revenue

79%

1

4 Otherincome

Sales

2

License Sales

split Q1 2024 4

2	3		3	Professional
			Services
	2%

4%

16%

Recurring revenue

Software revenue

Semi-recurring

5

…from solid public healthcare customers

>20

years

>10

years

Note: 1) Churn of recurring revenue from lost contracts

Solid counterparties

+90% of revenue from public healthcare accounts

High stickiness

Predictable revenues for years, sometimes decades

High diversification

+600 contracts across

27 countries

• 2% churn1)

Mission-critical systems favours contract continuity

6

Performance Q1-2024 compared to Q1-2023

106 MNOK

Q1'24

vs 102 MNOK Q1'23

7,1%

COGS Q1'24

vs 8,4% Q1'23

5%

Organic growth

Q1'24 vs Q1'23

63,4%

Salary cost Q1'24

vs 70,7% Q1'23

(% of total revenue)

83%

License sales & recurring revenue

291

Employees

Q1'24

vs 297 Q1'23

14%

EBITDA margin Q1'24

vs 5% Q1'23

14,8%

Other cost Q1'24

vs 15,6% Q1'23

(% of total revenue)

7

Q1-2024 - Overall income & cost reflections

Ok

Ok

Weak

Ok

High

Ok

Professional Services in Q1'24 are lower than expected

Q1'24 has a resource pool cost with higher income potential than displayed in the quarter

8

Omda's key building blocks and value creation model

Revenue build-up

IV

III

II

I

M&A as an integral part of Omda's DNA through a clearly defined BIB strategy

Acquired revenue

Profitable organic growth

Public customer base of long-term recurring revenues

Specialised software for healthcare and emergency response

Large underlying market with structural growth

9

Omda's history and direction

Start-up	Export	#1	Profitability	Europe	Worldwide
Norwegian	Export to	The #1 in niche	Decentralisation	Focus on strong	Leader in
start-up in	Sweden & small	software in the	and margin	growth in	specialised
hospital	acquisitions	Nordics	improvement	Europe	niches

1999 - 2009	2010 - 2014	2015 - 2021	2022 - 2023	2025	2030
15 companies acquired & integrated		Business plan priorities
SmartWare				Organic	Profitability
				growth

Natus

Cash discipline

Acquisitions